TrialInternational journal of clinical oncology2013

Weekly low-dose docetaxel combined with estramustine and dexamethasone for Japanese patients with metastatic castration-resistant prostate cancer.

Koji Hatano et al.PubMed ↗Publisher ↗

No numbers read from the abstract.